CCL3 and chronic obstructive pulmonary disease: Antagonism of CCL3 resulted in a significant reduction in CD14+ monocyte migration towards COPD sputum supernatant implicating this chemokine in the processes that control monocyte/macrophage trafficking and positioning within the lungs of COPD patients.